Get started
Author

Mila Poelhekken

Institution: Alrijne Ziekenhuis
ORCID: 0000-0002-6022-7851
Observed ORCID: 0000-0002-6022-7851
OpenAlex ID: A5048076990
Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28‐week clinical and biomarker results from the BioDay registry
2022 · Esmé Kamphuis, Celeste M. Boesjes, et al. · Pediatric Allergy and Immunology · 29
PDF
Dupilumab in daily practice for the treatment of Pediatric Atopic Dermatitis: 16-week clinical and biomarker results from the BioDay registry
2024 · Esmé Kamphuis, Celeste M. Boesjes, et al. · 4
PDF
The positive impact of rituximab on the quality of life and mental health in patients with pemphigus
2022 · Hanan Rashid, Mila Poelhekken, et al. · JAAD International · 4
PDF
Dermatologists’ Perspectives on Skincare Routine Trends
2026 · Mila Poelhekken, Sebastiaan van der Bent · Clinical Cosmetic and Investigational Dermatology · 2
PDF
Practitioner-Reported Complications in Tattoo Removal
2026 · Mila Poelhekken, Peter J. Velthuis, et al. · Dermatology · 1
Punch biopsies in tattooed skin: Complications and patient‐reported outcomes
2024 · Mila Poelhekken, Ines J. Schornagel, et al. · JEADV Clinical Practice · 1
PDF
Dupilumab in a child with severe atopic dermatitis and severe asthma—a rare case with severe limbitis and exercise‐induced anaphylaxis
2022 · Mila Poelhekken, Fieke M. Rosenberg, et al. · International Journal of Dermatology · 1
Works count: 7
Citation count: 42
H-index: 3
I10-index: 1
Year
Topic
Type